Malaria treatment safety in early pregnancy
Treatments studied
Part of Infections clinical trials.
This trial tests how safe antimalarial drugs are during the first few months of pregnancy. It aims to find treatments that protect both mother and baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 2 weeks and 14 weeks pregnant (as confirmed by ultrasound).
- You have a malaria infection with the P. falciparum parasite, with or without symptoms.
- You are at least 16 years old or an emancipated minor.
- You live near a participating health center and plan to deliver there.
- You agree to follow the study schedule and deliver at the local facility.
- You have not taken certain antimalarial medicines in the last 2 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a malaria prevention drug (DHA-PQP) to pregnant women in Kasese District can reduce malaria in pregnancy. Pregnant women at Bugoye Health Center who are less than 22 weeks along may join.
This study follows people who were pregnant while receiving IV artesunate to better understand the treatment’s safety for both the mother and the baby. It does not test a new treatment—it collects safety information from real-world care.
This study measures how a medicine called an 8-aminoquinoline passes into breast milk after birth, to help prevent malaria in new mothers. If you and your baby have normal G6PD levels and you plan to exclusively breastfeed, this trial may be for you.
This trial tests if giving two malaria medicines together (dihydroartemisinin piperaquine and primaquine) to everyone in a community can help reduce malaria. It is for people living in high-risk areas in eastern Ghana.
This trial tests a combination of three malaria medicines in healthy volunteers to see how safe they are and how the body processes them. If you are a healthy non-smoker, you may be able to help researchers understand these drugs better.
This trial studies how artesunate works in infants under 2 years old being treated for severe malaria. It aims to learn more about the medicine to help improve treatment for babies.
Hear when a new Malaria, Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.